Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucose Transporter Protein Type 1 Deficiency Syndrome”

Showing 4 of 0 results

Not applicableStudy completedNCT04399954
What this trial is testing

Evaluation of Ketoflo

Who this might be right for
Epilepsy IntractableGlucose Transporter Type 1 Deficiency SyndromeKetogenic Dieting
Vitaflo International, Ltd 25
Testing effectiveness (Phase 2)Study completedNCT01993186
What this trial is testing

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Ultragenyx Pharmaceutical Inc 36
Large-scale testing (Phase 3)Ended earlyNCT02960217
What this trial is testing

Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Ultragenyx Pharmaceutical Inc 44
Testing effectiveness (Phase 2)UnknownNCT02000960
What this trial is testing

Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome
University of British Columbia 3

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation